Provectus Biopharmaceuticals, Inc.
PVCT
$0.07
$0.017.88%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 235.07% | -80.56% | -1.15% | 27.00% | 63.95% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 117.11% | -23.88% | -16.06% | -29.51% | 70.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -19.60% | 160.17% | -58.15% | -80.16% | -1.50% |
| Total Current Assets | 104.28% | -51.08% | -12.50% | -33.51% | 28.53% |
|
|
|||||
| Total Current Assets | 104.28% | -51.08% | -12.50% | -33.51% | 28.53% |
| Net Property, Plant & Equipment | -8.67% | -7.92% | 817.26% | -43.05% | -29.76% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 66.11% | -41.87% | 8.42% | -33.79% | 25.47% |
|
|
|||||
| Total Accounts Payable | -39.19% | -10.16% | 76.21% | -32.77% | -19.87% |
| Total Accrued Expenses | 11.44% | 7.01% | 17.62% | 0.36% | 38.78% |
| Short-term Debt | 105.67% | 95.03% | -56.42% | -39.66% | 86.88% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.62% | -5.69% | -3.93% | -17.65% | 10.69% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -82.89% | -4.08% |
| Total Other Current Liabilities | -- | -- | -- | -82.89% | -4.08% |
| Total Current Liabilities | 6.58% | -0.33% | 13.22% | -17.78% | 12.06% |
|
|
|||||
| Total Current Liabilities | 6.58% | -0.33% | 13.22% | -17.78% | 12.06% |
| Long-Term Debt | 0.00% | -- | -- | -- | -- |
| Short-term Debt | 105.67% | 95.03% | -56.42% | -39.66% | 86.88% |
| Capital Leases | -13.54% | -11.84% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.27% | -0.15% | 15.03% | -17.78% | 12.06% |
|
|
|||||
| Common Stock & APIC | 0.40% | 0.41% | 0.41% | 0.79% | 0.73% |
| Retained Earnings | -0.45% | -0.50% | -0.70% | -0.44% | -0.93% |
| Treasury Stock & Other | 0.17% | 0.17% | 0.49% | 0.00% | -0.83% |
| Total Common Equity | -2.40% | -4.76% | -15.02% | 14.33% | -9.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.34% | 1.36% | 2.08% | 2.13% | 0.71% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.34% | 1.36% | 2.08% | 2.13% | 0.71% |
|
|
|||||
| Total Common Equity | -2.40% | -4.76% | -15.02% | 14.33% | -9.87% |
| Total Preferred Equity | 1.34% | 1.36% | 2.08% | 2.13% | 0.71% |
| Total Minority Interest | 75.31% | -326.32% | -111.24% | 441.41% | -- |
| Total Equity | -2.20% | -4.97% | -15.90% | 15.08% | -10.08% |
|
|
|||||